Foravirumab (Anti-Rabies virus GP)

Foravirumab (Anti-Rabies virus GP) is a monoclonal antibody targeting rabies virus glycoprotein antigenic site III. It is suitable in treatment of rabies postexposure prophylaxis. MW :144.44 KD.
Supplier Selleck Chemicals
Product # A3125
Sku # A3125-1mg*5
Pricing 1mg*5, $970.00
Feedback